logo
#

Latest news with #870.00

Furukawa Electric Co (FUWAF) Gets a Hold from UBS
Furukawa Electric Co (FUWAF) Gets a Hold from UBS

Business Insider

time15 hours ago

  • Business
  • Business Insider

Furukawa Electric Co (FUWAF) Gets a Hold from UBS

UBS analyst Harunobu Goroh maintained a Hold rating on Furukawa Electric Co (FUWAF – Research Report) today and set a price target of Yen6,870.00. The company's shares closed last Tuesday at $48.30. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Goroh covers the Industrials sector, focusing on stocks such as Furukawa Electric Co, Itochu, and Mitsui & Co. According to TipRanks, Goroh has an average return of 4.3% and a 66.67% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Furukawa Electric Co with a $31.70 average price target. Based on Furukawa Electric Co's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $311.65 billion and a net profit of $5.17 billion. In comparison, last year the company earned a revenue of $262.19 billion and had a GAAP net loss of $2.38 billion

Jefferies Reaffirms Their Buy Rating on Mankind Pharma Ltd. (MANKIND)
Jefferies Reaffirms Their Buy Rating on Mankind Pharma Ltd. (MANKIND)

Business Insider

time25-05-2025

  • Business
  • Business Insider

Jefferies Reaffirms Their Buy Rating on Mankind Pharma Ltd. (MANKIND)

Jefferies analyst Alok Dalal maintained a Buy rating on Mankind Pharma Ltd. (MANKIND – Research Report) on May 23 and set a price target of INR2,870.00. The company's shares closed last Friday at INR2,425.00. Confident Investing Starts Here: According to TipRanks, Dalal is ranked #4967 out of 9536 analysts. In addition to Jefferies, Mankind Pharma Ltd. also received a Buy from J.P. Morgan's Bansi Desai in a report issued on May 21. However, on the same day, Bank of America Securities maintained a Sell rating on Mankind Pharma Ltd. (NSE: MANKIND).

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store